Trial Profile
A Phase I/II Clinical Study of JNJ-30979754 (Decitabine) in Patients With Myelodysplastic Syndrome
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 11 Jan 2022
Price :
$35
*
At a glance
- Drugs Decitabine (Primary)
- Indications Myelodysplastic syndromes
- Focus Adverse reactions; Therapeutic Use
- 16 Apr 2012 Actual initiation date changed from Oct 2010 to Jul 2012 as reported by ClinicalTrials.gov.
- 21 Oct 2010 Actual end date (October 2010) added as reported by ClinicalTrials.gov.
- 21 Oct 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.